Immediate reaction
Harvey's confidence level spoke volumes.
Harvey just about told us that a new molecule, to treat resistance in other cancer indications, will be introduced this year. Would any of the scientists on the board care to take a guess as to which indication?
By offfering compassionate use throughout the world, Harvey is accomplishing the following:
1- Creating a relationship with oncologists outside of the USA and Europe.
2- Building a worldwide market for Ponatinib, so that we will be up and running from day one of the approval.
I may have some other comments after I listen the the preentation again tonight.
As usual, this is JMHO,
Barry
